Bioprofarma Bago
Buenos Aires, Argentina· Est.
Latin biotech delivering oncology and specialty medicines across Latin America through manufacturing and strategic partnerships.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Latin biotech delivering oncology and specialty medicines across Latin America through manufacturing and strategic partnerships.
OncologyHematologyUrologyRare DiseasesSpecial Treatments
Technology Platform
Small‑molecule drug development, formulation, and GMP manufacturing combined with strategic in‑licensing of novel therapeutic candidates.
Opportunities
Expansion of in‑licensing agreements and geographic reach into underserved Latin American markets will drive pipeline growth and revenue diversification.
Risk Factors
Regulatory delays, reimbursement challenges, and competition from larger multinational specialty pharma could limit market penetration.
Competitive Landscape
Regional specialty pharma such as Laboratorio Richmond and Pharmalgen compete on similar therapeutic areas, but Bioprofarma Bagó differentiates through its manufacturing capacity and patient‑centric pharmacovigilance model.